APA Citatie

Modi, P., Balakrishnan, K., Yang, Q., Wierda, W. G., Keating, M. J., & Gandhi, V. (2017). Idelalisib and bendamustine combination is synergistic and increases DNA damage response in chronic lymphocytic leukemia cells. Oncotarget.

Chicago Style citaat

Modi, Prexy, Kumudha Balakrishnan, Qingshan Yang, William G. Wierda, Michael J. Keating, en Varsha Gandhi. "Idelalisib and Bendamustine Combination Is Synergistic and Increases DNA Damage Response in Chronic Lymphocytic Leukemia Cells." Oncotarget 2017.

MLA citatie

Modi, Prexy, et al. "Idelalisib and Bendamustine Combination Is Synergistic and Increases DNA Damage Response in Chronic Lymphocytic Leukemia Cells." Oncotarget 2017.